Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®

Clinical trial NCT06298409 · RECRUITING

Trial details

NCT number: NCT06298409
Sponsor: Envivo Bio Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Intestinal Bacterial Overgrowth

Start date: 2024-02-15
Primary completion: 2026-02-28
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.